Summer Program

Faculty

 

The O'Neill Institute Summer Program on Emerging Issues in Food and Drug Law will convene leading practitioners, policymakers, advocates, and academics in food and drug law for a series of interactive lectures, panel discussions, and case studies. Invited speakers include current and former officials from the FDA, the FTC, and the EPA.

Director

Professor Sam Halabi (HAL uh bee), J.D., M.Phil., is an O'Neill Institute Scholar and an Associate Professor at the University of Tulsa College of Law. Between 2008 and 2010, he served as a Fellow at O'Neill and an Adjunct Professor of Law at Georgetown University Law Center. In 2008, he assisted the Presidential Health Care Policy Working Group on approaches to international food and drug inspections. In 2010, Professor Halabi addressed a special committee of the United Nations on the relationship between decentralized health care systems and social inclusion as well as the U.N. Committee on the Elimination of All Forms of Discrimination Against Women on Egypt's compliance with the World Health Organization's Framework Convention on Tobacco Control.

He currently serves as the 2014 Director of the O’Neill Institute’s Summer Program on Emerging Issues in Food and Drug Law. His recent policy work focuses on identifying and minimizing legal barriers to global vaccine availability. He is a member of the Editorial Board of the Food and Drug Law Journal as well as a member of the American Society of Law, Medicine and Ethics. His work has been published or is forthcoming in the Harvard International Law Journal, the Journal of Law, Medicine, and Ethics, the Michigan Journal of International Law, and the Northwestern Journal of International Law and Business, among others.

Confirmed Speakers

Alberto Alemanno
Jean Monnet Professor of EU Law and Risk Regulation, HEC-Paris
Scholar, O'Neill Institute for National and Global Health Law

Jodi Avergun
Partner, Cadwalader, Wickersham and Taft, LLP

Ilisa B.G. Bernstein
Deputy Director, Office of Compliance, Center for Drug Evaluation and Research,
U.S. Food and Drug Administration

Parth Chanda
Senior Corporate Counsel, Compliance, Pfizer Pharmaceuticals

Philip Chen
Assistant General Counsel, Office of the US Trade Representative

Katherine Cooper
Senior Policy and Strategy Analyst, Office of Strategy, Partnerships, and Analytics, Office of International Programs, U.S. Food and Drug Administration

Sandra Eskin
Director, Food Safety, The Pew Charitable Trusts

James Fitzgerald
Director of Health Systems and Services, PAHO/WHO

Michele Forzley
Senior Scholar and Careers and Externships Advisor, O'Neill Institute for National and Global Health Law
Distinguished Visiting Scholar, Health Law Institute, Widener University School of Law

Bruce Gellin
Deputy Assistant Secretary for Health; Director, National Vaccine Program Office, US Department of Health and Human Services (HHS)

Aliza Glasner
Institute Associate, O'Neill Institute for National and Global Health Law

Ariel Glasner
Associate, Blank Rome, LLP

Jesse Goodman
Director, Center on Medical Product Access, Safety and Stewardship (COMPASS), Georgetown University Medical Center
Former Chief Scientist, US Food and Drug Administration

Jeffrey Gren
Board Member, Alliance for Safe Online Pharmacies; President, Gren International Health & Trade Consulting; and Former Director, U.S. Department of Commerce, Office of Health and Information Technology

Ben Haas
Partner, Latham & Watkins

Margaret Hamburg
Commissioner, US Food and Drug Administration

Sabine Haubenreisser
European Medicines Agency, Liaison Official to US FDA; Former Secretary to the Mutual Recognition Facilitation Group and former Specialised Group Leader of the Team Anti-Infectives, Immunology, Gastroenterology and Musculoskeletal in the Post-Authorisation Human Unit

Lisa Heinzerling
William J. Brennan, Jr. Professor of Law, Georgetown University Law Center
Former Associate Administrator, US Environmental Protection Agency Office of Policy, 2009-2010

Susan Kim
Deputy Director, O'Neill Institute for National and Global Health Law

Sharon Mayl
Senior Advisor for Policy to the Deputy Commissioner for Foods and Veterinary Medicine, US Food and Drug Law Administration

Benn McGrady
Project Director, Trade, Investment and Health Initiative, O'Neill Institute for National and Global Health Law
Adjunct Professor, Georgetown University Law Center

John Monahan
Senior Advisor to the President for Global Health and Senior Fellow, McCourt School of Public Policy, Georgetown University
Former Counselor to the Secretary and Director, Office of Global Health Affairs, US Department of Health and Human Services (HHS)

Joseph Page
Professor of Law, Georgetown University Law Center
Director, Center for the Advancement of the Rule of Law in the Americas

Gordon Schatz
Asia Integration Partner, Life Sciences Health Industry Group, Reed Smith, LLP

Marc Scheineson
Partner, Chair, Food and Drug Law Practice Group, Alston & Bird, LLP

Vince H. Suneja
Chief Executive Officer, TwoFour Insight Group, LLC; Former First Secretary, Market Access & Compliance Attaché at the U.S. Embassy in New Delhi, India

Doug Stearn
Deputy Director Policy and Analysis, US Food and Drug Administration

David Vladeck
Professor of Law, Georgetown University Law Center
Former Director of the Bureau of Consumer Protection, Federal Trade Commission

Chris Waldrop
Director, Food Policy Institute, Consumer Federation of America

Susan Weld
Executive Director, Law Asia Leadership, Adjunct Professor of Law, Georgetown University Law Center

Timothy Westmoreland
Professor of Practice, Georgetown University Law Center
Former Counsel to the Subcommittee on Health and the Environment, US Health of Representatives

Samuel R. Wiseman
Assistant Professor, Florida State University

Derek Yach
Senior Vice President of the Vitality Group
Former Executive Director for Noncommunicable Diseases and Mental Health, World Health Organization

Jennifer Zachary
Partner, Food and Drug Practice Group, Covington and Burling, LLP

Ed Zhao
Vice President, Global Education and Training, U.S. Pharmacopeial Convention (USP)